Supply Chain
Standards on the Frontlines: Responding to public health crises and strengthening sup...
Vulnerabilities or disruptions to the global medicine supply chain (including drug shortages) continue to make headlines.
Standards Enable a Strong Medicines Supply Chain
Standards play an important role in the global medicines supply chain, helping governments and manufacturers increase the availability of safe, quality medicines, as well as building patient and health provider trust. In fact, quality standards are a big reason why we in the U.S. can get a prescription filled at our neighborhood pharmacy and trust that the medicine we receive will be safe and work as it should.
Mitigating Cancer Drug Shortages: USP-American Cancer Society Summit Issues Call to A...
Patient access to cancer drugs can mean the difference between life and death. Persistent shortages threaten patients’ access to the lifesaving and life-sustaining therapies they need.
Ensuring Product Safety: U.S. FDA Guidance on Testing High-Risk Drug Components for D...
Pharmaceutical Continuous Manufacturing: A Guide to Control Strategies for Solid Oral...
Advanced manufacturing technologies like pharmaceutical continuous manufacturing (PCM) can provide potential efficiencies for many medicines and their ingredients, thereby facilitating geographic diversity in manufacturing and supply chain resilience. One of the ways the U.S.
Vietnam pilot project spotlights the importance of international collaboration to con...
A recently completed pilot project in Vietnam to validate and implement monitoring procedures for nitrosamine impurities in medicines is an inspiring example of how international collaboration and cooperation can help ensure medicines quality across geographies and strengthen the supply chain.
Supplier qualification standard aims to strengthen supply chains for quality medicine...
USP’s supplier qualification standard became official on Aug.
Complex generics: Are global regulators addressing the needs? ...
The development of generic versions of innovator medicines is a global public health need.